Glycotest is a liver disease diagnostics company commercializing new and unique blood tests for life threatening liver cancers and fibrosis-cirrhosis. Founded in 2012 by NetScientific plc on technology innovated by two experts in the fields of liver disease and glycobiology−Professors Timothy Block and Anand Mehta at Drexel University College of Medicine and the Baruch S. Blumberg Institute, we have exclusive, world-wide rights to over 50 patent-protected serum glycoprotein biomarkers, biomarker panels and algorithms, and novel assay technology that exploit sugar-based disease signals